| Samuel Allen Fagenholz, MD | |
|
300 State St Ste 301, Erie, PA 16507-1430 | |
| (814) 877-7907 | |
| (814) 877-6791 |
| Full Name | Samuel Allen Fagenholz |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 300 State St Ste 301, Erie, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376549998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD021621E (Pennsylvania) | Primary |
| 2080P0214X | Pediatrics - Pediatric Pulmonology | MD021621E (Pennsylvania) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Allen Fagenholz, MD 300 State St Ste 301, Erie, PA 16507-1430 Ph: (814) 877-7907 | Samuel Allen Fagenholz, MD 300 State St Ste 301, Erie, PA 16507-1430 Ph: (814) 877-7907 |
News Archive
LENSAR Inc., developer of the next generation LENSAR Laser System™ for refractive cataract surgery, announced today that the company's laser system has received 510(k) clearance from the United States Food and Drug Administration (FDA) for executing corneal incisions during cataract surgery.
Urologists at Henry Ford Hospital have developed a new technique that could make minimally invasive robotic partial nephrectomy procedures the norm, rather than the exception for kidney cancer patients. The technique spares the kidney, eliminates long hospital stays and provides better outcomes by giving the surgeon more time to perform the procedure.
Violent behavior and beliefs among middle school students can be reduced through the implementation of a targeted violence intervention program, according to a Vanderbilt study released in the Journal of Injury and Violence Research.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that the next clinical trial of plecanatide to treat chronic idiopathic constipation patients, planned to begin in the second quarter of 2011, has been designed as a Phase II/III trial.
SARS-CoV-2 has spread around the world, passed across the borders of nations by travelers and cargo.
› Verified 8 days ago
Joseph C Barber, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3580 Peach St, Erie, PA 16508 Phone: 814-868-9633 Fax: 814-866-1436 | |
Cynthia Weibel, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3580 Peach St, Suite 100, Erie, PA 16508 Phone: 814-868-9633 | |
Dr. Lynne M Birkmeyer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1202 State St, Erie, PA 16501 Phone: 814-454-4530 | |
Michael Balsan, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 201 State St, Nicu Department, Erie, PA 16550 Phone: 814-877-6000 | |
Shannon Moore, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 State St, Suite 301, Erie, PA 16507 Phone: 814-877-7907 | |
Maria Irma Santos Leonard, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4022 Zuck Rd, Erie, PA 16506 Phone: 814-877-5424 Fax: 814-877-5423 | |
Sant Ram, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2123 W 8th St, Erie, PA 16505 Phone: 814-453-5056 |